Patrick Trucchio Analyst PerformanceAnalyst at HC WainwrightPatrick Trucchio is a stock analyst at HC Wainwright focused in the healthcare sector, covering 27 publicly traded companies. Over the past year, Patrick Trucchio has issued 1 stock ratings, including and buy recommendations. While full access to Patrick Trucchio's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick Trucchio's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings129 Last 7 YearsBuy Recommendations98.41% 124 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution126RatingsDistribution of strong buy, buy, hold, and sell ratings by Patrick Trucchio.RatingPercentageCount Strong Buy0.0%0 ratings Buy98.4%124 ratings Hold1.6%2 ratings Sell0.0%0 ratingsOut of 126 total stock ratings issued by Patrick Trucchio at HC Wainwright, the majority (98.4%) have been Buy recommendations, followed by 1.6% Hold.Best & Worst CallsBest Call000000.0%ANROApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%DTILOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ81.5% of companies on NASDAQ22 companiesNYSE7.4% of companies on NYSE2 companiesTSE7.4% of companies on TSE2 companiesOTCMKTS3.7% of companies on OTCMKTS1 companyPatrick Trucchio, an analyst at HC Wainwright, currently covers 27 companies listed on NASDAQ, NYSE, TSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare26 companies96.3%Finance1 company3.7%Patrick Trucchio of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Finance companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY15 companies55.6%PHARMACEUTICALS10 companies37.0%BANKS1 company3.7%HEALTHCARE PROVIDERS & SERVICES1 company3.7% Patrick Trucchio's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsANROAlto Neuroscience6/17/2026Reiterated Rating$21.03Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals11/4/2025Set Price Target$434.07$570.00Buy$000.0000.00% ROIQUREuniQure11/4/2025Lower Price Target$34.29$70.00Buy$00.0000.00% ROIASMBAssembly Biosciences8/18/2025Initiated Coverage$25.44$50.00Buy$00.0000.00% ROIALTAltimmune8/13/2025Reiterated Rating$3.85$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/7/2025Boost Price Target$428.14$570.00Buy$000.0000.00% ROICMPSCompass Pathways8/4/2025Lower Price Target$4.73$40.00Buy$00.0000.00% ROIATAIAtai Beckley7/30/2025Reiterated Rating$3.49$15.00Buy$0.0000.00% ROICMPSCompass Pathways7/15/2025Reiterated Rating$3.64$45.00Buy$00.0000.00% ROIALTAltimmune6/27/2025Reiterated Rating$3.61$12.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IVVDInvivyd6/26/2025Reiterated Rating$0.77$5.00Buy$0.0000.00% ROISGMOSangamo Therapeutics6/24/2025Reiterated Rating$0.50$10.00Buy$0.0000.00% ROISLNSilence Therapeutics6/13/2025Reiterated Rating$5.59$75.00Buy$0.0000.00% ROIIMCRImmunocore6/2/2025Reiterated Rating$38.51$100.00Buy$00.0000.00% ROIQUREuniQure5/29/2025Reiterated Rating$15.33$70.00Buy$00.0000.00% ROIIVVDInvivyd5/28/2025Lower Price Target$0.88$5.00Buy$0.0000.00% ROIONCYOncolytics Biotech5/21/2025Reiterated Rating$0.43$5.00Buy$0.0000.00% ROIDTILPrecision BioSciences5/21/2025Reiterated Rating$4.88$60.00Buy$0.0000.00% ROIATAIAtai Beckley5/20/2025Reiterated Rating$1.84$10.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals5/20/2025Reiterated Rating$15.74$80.00Buy$00.0000.00% ROICMPSCompass Pathways5/12/2025Reiterated Rating$3.79$45.00Buy$0.0000.00% ROIGHRSGH Research5/9/2025Reiterated Rating$10.94$40.00Buy$00.0000.00% ROIQUREuniQure4/21/2025Reiterated Rating$13.72$70.00Buy$00.0000.00% ROIVYGRVoyager Therapeutics4/8/2025Reiterated Rating$2.93$30.00Buy$0.0000.00% ROIBEAMBeam Therapeutics4/7/2025Reiterated Rating$15.27$80.00Buy$00.0000.00% ROISGMOSangamo Therapeutics4/7/2025Reiterated Rating$0.66$10.00Buy$0.0000.00% ROIANROAlto Neuroscience4/7/2025Initiated Coverage$1.87$10.00Buy$00.0000.00% ROIALTAltimmune4/3/2025Reiterated Rating$4.61$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals4/2/2025Reiterated Rating$261.73$500.00Buy$000.0000.00% ROIDTILPrecision BioSciences3/28/2025Reiterated Rating$4.54$60.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals3/28/2025Reiterated Rating$0.95$25.00Buy$0.0000.00% ROIIVVDInvivyd3/26/2025Reiterated Rating$0.66$10.00Buy$0.0000.00% ROIATAIAtai Beckley3/19/2025Reiterated Rating$1.38$10.00Buy$0.0000.00% ROIDTILPrecision BioSciences3/19/2025Reiterated Rating$4.91$60.00Buy$0.0000.00% ROIGOSSGossamer Bio3/18/2025Reiterated Rating$111.20$800.00Buy$00.0000.00% ROIALTAltimmune3/18/2025Reiterated Rating$5.97$12.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals3/17/2025Reiterated Rating$2.45$25.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/13/2025Reiterated Rating$4.06$30.00Buy$0.0000.00% ROIIMCRImmunocore3/12/2025Reiterated Rating$28.42$100.00Buy$00.0000.00% ROIBEAMBeam Therapeutics3/10/2025Reiterated Rating$24.32$80.00Buy$00.0000.00% ROIToday's free pick (on me) (Ad)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.Get today's free pick before December 8th.ONCYOncolytics Biotech3/10/2025Reiterated Rating$0.66$5.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics3/7/2025Reiterated Rating$6.61$55.00Buy$00.0000.00% ROISLNSilence Therapeutics3/7/2025Reiterated Rating$4.74$75.00Buy$0.0000.00% ROICMPSCompass Pathways3/4/2025Reiterated Rating$3.75$45.00Buy$0.0000.00% ROIQUREuniQure3/4/2025Reiterated Rating$10.76$70.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/3/2025Reiterated Rating$4.00$30.00Buy$0.0000.00% ROIALTAltimmune3/3/2025Reiterated Rating$6.24$12.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/28/2025Reiterated Rating$27.27$80.00Buy$00.0000.00% ROIMISTMilestone Pharmaceuticals2/28/2025Reiterated Rating$1.75$25.00Buy$0.0000.00% ROIVIRVir Biotechnology2/28/2025Reiterated Rating$8.01$110.00Buy$0.0000.00% ROIIMCRImmunocore2/28/2025Reiterated Rating$29.13$100.00Buy$00.0000.00% ROIIVVDInvivyd2/24/2025Reiterated Rating$1.43$10.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/24/2025Boost Price Target$252.00$500.00Buy$000.0000.00% ROIDTILPrecision BioSciences2/19/2025Reiterated Rating$5.63$60.00Buy$0.0000.00% ROIATAIAtai Beckley2/13/2025Reiterated Rating$2.55$10.00Buy$0.0000.00% ROIHELPCybin2/13/2025Lower Price Target$9.36$150.00Buy$0.0000.00% ROICMPSCompass Pathways2/13/2025Lower Price Target$4.25$45.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals2/12/2025Reiterated Rating$18.57$80.00Buy$00.0000.00% ROIALTAltimmune2/5/2025Reiterated Rating$6.88$12.00Buy$0.0000.00% ROIIVVDInvivyd2/4/2025Reiterated Rating$1.06$10.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/3/2025Reiterated Rating$25.92$80.00Buy$00.0000.00% ROIONCYOncolytics Biotech2/3/2025Reiterated Rating$0.73$5.00Buy$0.0000.00% ROIVIRVir Biotechnology1/31/2025Reiterated Rating$10.31$110.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics1/31/2025Reiterated Rating$7.13$55.00Buy$00.0000.00% ROIGOSSGossamer Bio1/30/2025Reiterated Rating$73.49$800.00Buy$000.0000.00% ROISLNSilence Therapeutics1/29/2025Reiterated Rating$5.28$75.00Buy$0.0000.00% ROIATAIAtai Beckley1/28/2025Reiterated Rating$1.42$10.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics1/27/2025Reiterated Rating$5.62$30.00Buy$0.0000.00% ROIQUREuniQure1/27/2025Boost Price Target$15.67$70.00Buy$00.0000.00% ROIGHRSGH Research1/27/2025Reiterated Rating$8.83$40.00Buy$00.0000.00% ROIIMCRImmunocore1/27/2025Reiterated Rating$33.00$100.00Buy$00.0000.00% ROISGMOSangamo Therapeutics1/27/2025Reiterated Rating$1.16$10.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals1/27/2025Reiterated Rating$2.05$25.00Buy$0.0000.00% ROIHELPCybin1/27/2025Reiterated Rating$9.46$190.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals1/23/2025Reiterated Rating$19.71$80.00Buy$00.0000.00% ROIALTAltimmune1/22/2025Reiterated Rating$6.94$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/13/2025Reiterated Rating$249.59$400.00Buy$000.0000.00% ROIDTILPrecision BioSciences1/10/2025Reiterated Rating$4.50$60.00Buy$0.0000.00% ROIGHRSGH Research1/10/2025Reiterated Rating$8.40$40.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
